BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37377750)

  • 21. Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative Breast Cancer.
    Humphries BA; Buschhaus JM; Chen YC; Haley HR; Qyli T; Chiang B; Shen N; Rajendran S; Cutter A; Cheng YH; Chen YT; Cong J; Spinosa PC; Yoon E; Luker KE; Luker GD
    Mol Cancer Res; 2019 May; 17(5):1142-1154. PubMed ID: 30718260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
    Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells.
    Ahir M; Bhattacharya S; Karmakar S; Mukhopadhyay A; Mukherjee S; Ghosh S; Chattopadhyay S; Patra P; Adhikary A
    Biomaterials; 2016 Jan; 76():115-32. PubMed ID: 26520043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine.
    Hu J; Zhang Y; Jiang X; Zhang H; Gao Z; Li Y; Fu R; Li L; Li J; Cui H; Gao N
    J Exp Clin Cancer Res; 2019 May; 38(1):225. PubMed ID: 31138329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced mitochondrial fission inhibits triple-negative breast cancer cell migration through an ROS-dependent mechanism.
    Humphries BA; Zhang A; Buschhaus JM; Bevoor A; Farfel A; Rajendran S; Cutter AC; Luker GD
    iScience; 2023 Jun; 26(6):106788. PubMed ID: 37235049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of oxidized low density lipoproteins and free fatty acids in the pathogenesis of glomerulopathy and tubulointerstitial lesions in type 2 diabetes.
    Nosadini R; Tonolo G
    Nutr Metab Cardiovasc Dis; 2011 Feb; 21(2):79-85. PubMed ID: 21186102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-Mediated Mitochondrial Dysfunction Is Involved in the Anti-triple-Negative Breast Cancer Cell Activity of Phytosesquiterpene Lactones.
    Cheng YT; Nakagawa-Goto K; Lee KH; Shyur LF
    Antioxid Redox Signal; 2023 Jan; 38(1-3):198-214. PubMed ID: 35850524
    [No Abstract]   [Full Text] [Related]  

  • 28. Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming.
    Pateras IS; Williams C; Gianniou DD; Margetis AT; Avgeris M; Rousakis P; Legaki AI; Mirtschink P; Zhang W; Panoutsopoulou K; Delis AD; Pagakis SN; Tang W; Ambs S; Warpman Berglund U; Helleday T; Varvarigou A; Chatzigeorgiou A; Nordström A; Tsitsilonis OE; Trougakos IP; Gilthorpe JD; Frisan T
    J Transl Med; 2023 Mar; 21(1):169. PubMed ID: 36869333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation.
    Shome R; Ghosh SS
    Cell Oncol (Dordr); 2021 Apr; 44(2):405-422. PubMed ID: 33398673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.
    Al Haq AT; Tseng HY; Chen LM; Wang CC; Hsu HL
    Cell Death Dis; 2022 Jan; 13(1):49. PubMed ID: 35017469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.
    Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL
    Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GROα overexpression drives cell migration and invasion in triple negative breast cancer cells.
    Bhat K; Sarkissyan M; Wu Y; Vadgama JV
    Oncol Rep; 2017 Jul; 38(1):21-30. PubMed ID: 28560447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion.
    Si L; Fu J; Liu W; Hayashi T; Nie Y; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
    Mol Cell Biochem; 2020 Jan; 463(1-2):189-201. PubMed ID: 31612353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
    Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment.
    Baek ML; Lee J; Pendleton KE; Berner MJ; Goff EB; Tan L; Martinez SA; Mahmud I; Wang T; Meyer MD; Lim B; Barrish JP; Porter W; Lorenzi PL; Echeverria GV
    Oncogene; 2023 Mar; 42(14):1117-1131. PubMed ID: 36813854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
    Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
    Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelargonic acid vanillylamide and rosuvastatin protect against oxidized low-density lipoprotein-induced endothelial dysfunction by inhibiting the NF-κB/NLRP3 pathway and improving cell-cell junctions.
    Sivasinprasasn S; Wikan N; Tocharus J; Chaichompoo W; Suksamrarn A; Tocharus C
    Chem Biol Interact; 2021 Aug; 345():109572. PubMed ID: 34217687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver.
    Demers A; Samami S; Lauzier B; Des Rosiers C; Ngo Sock ET; Ong H; Mayer G
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2517-25. PubMed ID: 26494228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling.
    He P; Sheng J; Qi J; Bai X; Li J; Wang F; Yuan Y; Zheng X
    Mol Biol Rep; 2022 Jan; 49(1):267-278. PubMed ID: 34846647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.